OCP levels (ng/g lipid) | Males: 325 case/control pairs | Females: 275 case/control pairs | p-interaction | ||||||
---|---|---|---|---|---|---|---|---|---|
N cases | N controls | OR | 95% CI | N cases | N controls | OR | 95% CI | ||
p,p’-DDE | |||||||||
 <LOD-78.56 | 66 | 73 | 1.00 | Ref. | 71 | 79 | 1.00 | Ref. |  |
 78.57-129.69 | 82 | 80 | 1.01 | (0.62–1.67) | 60 | 70 | 1.01 | (0.59–1.73) |  |
 129.70-233.49 | 97 | 90 | 1.03 | (0.63–1.71) | 75 | 58 | 1.52 | (0.88–2.63) |  |
 233.50-2,049.00 | 80 | 82 | 0.84 | (0.47–1.49) | 69 | 68 | 1.27 | (0.67–2.39) |  |
 p-trend |  |  |  | 0.55 |  |  |  | 0.59 | 0.76 |
p,p’-DDT | |||||||||
 <LOD | 178 | 192 | 1.00 | Ref. | 158 | 174 | 1.00 | Ref. |  |
 ≥LOD-6.30 | 47 | 47 | 0.96 | (0.60–1.53) | 22 | 29 | 0.91 | (0.49–1.71) |  |
 6.31–10.35 | 51 | 43 | 1.05 | (0.61–1.80) | 53 | 37 | 1.70 | (0.97–2.98) |  |
 10.36–126.80 | 47 | 40 | 1.18 | (0.68–2.05) | 37 | 30 | 1.50 | (0.80–2.84) |  |
 p-trend |  |  |  | 0.61 |  |  |  | 0.51 | 0.78 |
HCB | |||||||||
 <LOD | 148 | 158 | 1.00 | Ref. | 135 | 157 | 1.00 | Ref. |  |
 ≥LOD-6.36 | 66 | 64 | 1.01 | (0.64–1.60) | 39 | 31 | 1.57 | (0.92–2.68) |  |
 6.37–8.64 | 47 | 43 | 1.05 | (0.63–1.74) | 33 | 42 | 1.01 | (0.56–1.83) |  |
 8.65–150.70 | 59 | 49 | 1.22 | (0.72–2.08) | 60 | 37 | 2.23 | (1.23–4.06) |  |
 p-trend |  |  |  | 0.56 |  |  |  | 0.02 | 0.30 |
Oxychlordane | |||||||||
 <LOD | 130 | 158 | 1.00 | Ref. | 139 | 152 | 1.00 | Ref. |  |
 ≥LOD-7.95 | 63 | 60 | 1.21 | (0.76–1.91) | 40 | 37 | 1.22 | (0.71–2.10) |  |
 7.96–12.65 | 67 | 51 | 1.43 | (0.88–2.32) | 48 | 46 | 1.24 | (0.70–2.18) |  |
 12.66–104.80 | 64 | 55 | 1.21 | (0.71–2.04) | 47 | 37 | 1.47 | (0.81–2.68) |  |
 p-trend |  |  |  | 0.28 |  |  |  | 0.27 | 0.86 |
trans-Nonachlor | |||||||||
 <LOD | 81 | 105 | 1.00 | Ref. | 102 | 104 | 1.00 | Ref. |  |
 ≥LOD-8.92 | 61 | 76 | 0.92 | (0.58–1.47) | 54 | 56 | 0.99 | (0.61–1.63) |  |
 8.93–15.84 | 85 | 66 | 1.66 | (1.02–2.70) | 56 | 65 | 0.92 | (0.56–1.57) |  |
 15.85–304.30 | 98 | 78 | 1.56 | (0.93–2.60) | 61 | 50 | 1.22 | (0.70–2.29) |  |
 p-trend |  |  |  | 0.07 |  |  |  | 0.56 | 0.26 |
β-HCCH | |||||||||
 <LOD | 246 | 250 | 1.00 | Ref. | 202 | 227 | 1.00 | Ref. |  |
 ≥LOD (2.77–153.80) | 74 | 68 | 0.88 | (0.57–1.35) | 68 | 47 | 1.76 | (1.07–2.89) | 0.10 |
Mirex | |||||||||
 <LOD | 266 | 265 | 1.00 | Ref. | 239 | 237 | 1.00 | Ref. |  |
 ≥LOD (2.88–348.20) | 57 | 57 | 1.03 | (0.65–1.63) | 31 | 33 | 0.90 | (0.50–1.62) | 0.73 |